Study of immunogenic properties of the candidate edible vaccine against human immunodeficiency and hepatitis B viruses based on transgenic tomato fruits

Doklady Biochemistry and Biophysics

Volumn 401, Issue 1-6, 2005, Pages 167-169

  Shchelkunov, S N ^a   Salyaev, R K ^b   Rekoslavskaya, N I ^b   Pozdnyakov, S G ^a   Nesterov, A E ^b   Sumtsova, V M ^b   Pakova, N V ^c   Mishutina, U O ^c   Kopytina, T V ^a   Hammond, R ^d  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b SIBERIAN INSTITUTE OF PLANT PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^c INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; DNA VACCINE; EDIBLE VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; T AND B CELLULAR IMMUNOGEN HEPATITIS B SURFACE ANTIGEN VACCINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRID GENE; IMMUNOGENICITY; MOUSE; NONHUMAN; PLASMID; TOMATO; TRANSGENIC PLANT; VIRUS VECTOR;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV-1; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; LYCOPERSICON ESCULENTUM; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED;

ANIMALIA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LYCOPERSICON ESCULENTUM;

EID: 20044368836     PISSN: 16076729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10628-005-0061-3     Document Type: Article

References (14)

1. Shchelkunov, S.N., Geneticheskaya inzheneriya (Genetic Engineering), Novosibirsk: Sib. Univ., 2004.
2. Rekoslavskaya, N.I., Salyaev, R.K., and Shchelkunov, S.N., in Izuchenie genoma i geneticheskaya transformatsiya rastenii (The Study of the Genome and Genetic Transformation of Plants), Novosibirsk: Nauka, 2001, pp. 193-210.
3. Yusibov, V., Modelska, A., Steplewski, K., et al., Proc. Natl. Acad. Sci. USA, 1997, vol. 94, no. 11, pp. 5784-5788.
4. Modelska, A., Dietzschold, B., Sleysh, N., et al., Proc. Natl. Acad. Sci. USA, 1998, vol. 95, no. 5, pp. 2481-2485.
5. Spitsin, S., Steplewski, K., Fleysh, M., et al., Proc. Natl. Acad. Sci. USA, 1999, vol. 96, no. 5, pp. 2549-2553.
6. Kapusta, J., Modelska, A., Figlerovicz, M., et al., FASEB J., 1999, vol. 13, pp. 1796-1799.
7. Kong, Q., Richter, L., Yang, Y.F., et al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 11539-11544.
8. Streatfield, S.J., Jilka, J.M., Hood, E.E., et al., Vaccine, 2001, vol. 19, pp. 2742-2748.
9. Warzecha, H., Mason, H.S., Lane, C., et al., J. Virol., 2003, vol. 77, pp. 8702-8711.
10. Shchelkunov, S.N., Nesterov, A.E., Ryazankin, I.A., et al., Dokl. Akad. Nauk, 2003, vol. 390, no. 6, pp. 834-838
11. [Dokl. Biochem. Biophys. (Engl. Transl.), 2003, vol. 390, pp. 180-183].
12. Shchelkunov, S.N., Salyaev, R.K., Rekoslavskaya, N.I., et al., Dokl. Akad. Nauk, 2004, vol. 396, no. 1, pp. 121-125
13. [Dokl. Biochem. Biophys. (Engl. Transl.), 2004, vol. 396, pp. 139-142].
14. Pozdnyakov, S.G., Gavrilenko, E.V., Kurmanova, E.N., et al., Biotekhnol., 2003, no. 5, pp. 37-43.